Screener
Citius Pharmaceuticals CTXR Q3 2025 Annual earnings
Reported December 25, 2025 · Before market open
Revenue$3.9M
EPS-$0.44Miss by $0.20
EPS estimate-$0.24
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Citius Pharmaceuticals report Q3 2025 earnings?
- Citius Pharmaceuticals (CTXR) reported Q3 2025 earnings on December 25, 2025 before market open.
- What were Citius Pharmaceuticals's Q3 2025 revenue and EPS?
- Citius Pharmaceuticals reported revenue of $3.9M and eps of $-0.44 for Q3 2025.
- Did Citius Pharmaceuticals beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.24 by $0.20.
- How did Citius Pharmaceuticals's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 2429.4% from $155.9K a year earlier and eps grew 74.8% from $-1.75.
- Where can I find Citius Pharmaceuticals's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001213900-25-125413) and the 10-K periodic report (0001213900-25-125333) directly on SEC EDGAR. The filing index links above go to sec.gov.
